Mads Jorgen Nohr Clausen

Presidente presso Clausen Controls Holding Ii ApS

40 anni

Health Technology

Finance

Profilo

Mads Jorgen Nohr Clausen is associated with Clausen Controls Holding II ApS as Chairman since 2022 and with MC2 Therapeutics Ltd.
as Director since 2008.

Posizioni attive di Mads Jorgen Nohr Clausen

Società	Posizione	Inizio
MC2 Therapeutics Ltd. MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005.	Direttore/Membro del Consiglio	25/06/2008
Clausen Controls Holding Ii ApS Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022.	Presidente	04/05/2022

Tutte le posizioni attive di Mads Jorgen Nohr Clausen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mads Jorgen Nohr Clausen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
MC2 Therapeutics Ltd. MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005.	Health Technology
Clausen Controls Holding Ii ApS Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022.	Finance

Vedi le connessioni aziendali